The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Design and accrual of S1417CD: Development of a prospective financial impact assessment tool in patients with metastatic colorectal cancer (mCRC).
 
Veena Shankaran
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Joseph M. Unger
No Relationships to Disclose
 
Amy K. Darke
No Relationships to Disclose
 
Jennifer Marie Suga
No Relationships to Disclose
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Abbott (I); Celgene; GlaxoSmithKline (I); Johnson & Johnson (I); Novartis (I)
 
Peter Kourlas
No Relationships to Disclose
 
Sreenivasa R Chandana
Honoraria - HERON
Consulting or Advisory Role - HERON
Research Funding - Abbvie (Inst); Alexion Pharmaceuticals (Inst); Alexion Pharmaceuticals (Inst); Alexo Therapeutics (Inst); ArQule (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); BeiGene (Inst); Cerulean Pharma (Inst); Constellation Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Dicerna (Inst); Formation Biologics (Inst); Forty Seven (Inst); Livzon (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Symphogen (Inst); TaiRx, Inc. (Inst)
 
Mark Allen O'Rourke
No Relationships to Disclose
 
Suma Satti
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Genentech; Merck
 
Diane Liggett
No Relationships to Disclose
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Scott David Ramsey
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Cascadian Therapeutics; Epigenomics; Genentech; Kite, a Gilead company; Merck; Seagen
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Microsoft (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bristol-Myers Squibb; Flatiron Health